Duyurular & Dokümanlar
Dosya İndir
Eğitim Bilgileri
2012 - 2014
2012 - 2014Tıpta Yandal Uzmanlık
University of Michigan, Tıp Fakültesi, Gastroenteroloji ve Hepatoloji, Amerika Birleşik Devletleri
2009 - 2012
2009 - 2012Tıpta Yandal Uzmanlık
Ege Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
2002 - 2008
2002 - 2008Tıpta Uzmanlık
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
1995 - 2001
1995 - 2001Lisans
İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Cerrahpaşa Tıp Pr. (İngilizce), Türkiye
Yabancı Diller
C2 Ustalık
C2 Ustalıkİngilizce
Araştırma Alanları
Avesis Araştırma Alanları:
Sağlık Bilimleri, Gastroenteroloji-(Hepatoloji)
WoS Araştırma Alanları:
Gastroenteroloji Ve Hepatoloji
Scopus Araştırma Alanları:
Gastroenteroloji
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Makaleler
Tümü (54)
SCI-E, SSCI, AHCI (36)
SCI-E, SSCI, AHCI, ESCI (41)
ESCI (2)
Scopus (40)
TRDizin (7)
Diğer Yayınlar (9)
2026
20261. Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome
Hod K., Marasco G., Colecchia L., Cremon C., Barbaro M. R., Cacciari G., et al.
Neurogastroenterology and Motility , cilt.38, sa.4, 2026 (SCI-Expanded, Scopus)
2026
20262. Efficacy and tolerability of tenofovir alafenamide fumarate prophylaxis in HBV-infected individuals receiving chemo/ immunosuppressive therapy
Dilber F., Durak S., Unsal Y., DEMİR M., Yildirim A. E., Ellik Z. M., et al.
Hepatology Forum
, cilt.7, sa.1, ss.26-31, 2026 (Scopus)
2025
20253. Long-Term Impact of COVID-19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities
Marasco G., Hod K., Colecchia L., Cremon C., Barbaro M. R., Cacciari G., et al.
United European Gastroenterology Journal , cilt.13, sa.5, ss.798-818, 2025 (SCI-Expanded, Scopus)
2025
20254. Neural-Mediated Laryngopharyngeal Reflux Disease and the Role of Esophageal Dysmotility
YAPALI S., Bor S.
Otolaryngologic Clinics of North America , cilt.58, sa.3, ss.451-463, 2025 (SCI-Expanded, Scopus)
2025
20255. Metabolic Dysfunction-Associated Steatotic Liver Disease in the MENA Region: Setting a Research and Action Priority Agenda.
El-Kassas M., Villota-Rivas M., Alswat K. A., AlNaamani K. M., Yilmaz Y., Labidi A., et al.
Liver international : official journal of the International Association for the Study of the Liver , cilt.45, sa.6, 2025 (SCI-Expanded, Scopus)
2024
20246. Yağlı Karaciğer Hastalığı: Yeni Terminolojilerin Anlaşılması ve Klinik Yönetim
Yapali S.
The Turkish Journal of Current Gastroenterology , cilt.25, ss.133-144, 2024 (Hakemli Dergi)
2023
20237. Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review
TABAK Ö. F., YAPALI S., Celen M. K., GÜNER H. R.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
, sa.2, ss.43-51, 2023 (ESCI)
2023
20238. TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.
Yilmaz Y., Zeybel M., Adali G., Cosar A. M., Sertesen E., Gokcan H., et al.
Hepatology forum , cilt.4, sa.Suppl 1, ss.1-32, 2023 (ESCI, Scopus, TRDizin)
2023
20239. Post COVID-19 irritable bowel syndrome
Marasco G., Cremon C., Barbaro M. R., Cacciari G., Falangone F., Kagramanova A., et al.
GUT , cilt.72, sa.3, ss.484-492, 2023 (SCI-Expanded, Scopus)
2022
202210. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis
Efe C., Tascilar K., Gerussi A., Bolis F., Lammert C., Ebik B., et al.
JOURNAL OF AUTOIMMUNITY , cilt.132, 2022 (SCI-Expanded, Scopus)
2022
202211. Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy
Gunduz F., DURAK S., Unsal Y., Demir M., Ellik Z. M., Yildirim A. E., et al.
JOURNAL OF HEPATOLOGY , 2022 (SCI-Expanded, Scopus)
2022
202212. Real life efficacy and tolerability of Tenofovir alafenamde fumarate in liver transplant recipients: a multicenter study
GÖKCAN H., YAPALI S., HARPUTLUOĞLU M. M. M., Ellik Z. M. L., Gokcen P., ADANIR H., et al.
JOURNAL OF HEPATOLOGY , 2022 (SCI-Expanded, Scopus)
2022
202213. Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study
Marasco G., Cremon C., Barbaro M. R., Salvi D., Cacciari G., Kagramanova A., et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY
, cilt.117, sa.1, ss.147-157, 2022 (SCI-Expanded, Scopus)
2021
202114. REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN PATIENTS WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS. A-PRELIMINARY RESULT
YAPALI S., GÖKCAN H., Harputluoglu M., Ellik Z. M., AKARSU M., DURAK S., et al.
HEPATOLOGY
, cilt.74, 2021 (SCI-Expanded, Scopus)
2021
202115. EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B VIRUS-INFECTED PATIENTS WITH CHRONIC HEMODIALYSIS AND RENAL TRANSPLANTATION: A PRELIMINARY RESULT
ADANIR H., Etik D. O., YILDIRIM A. E., Mehdiyev S., YAPALI S., COŞAR A. M., et al.
HEPATOLOGY
, cilt.74, 2021 (SCI-Expanded, Scopus)
2021
202116. Long-term Kinetics of Alpha-fetoprotein in Chronic Hepatitis C Patients Treated with Direct-acting Antivirals and Possible Predictive Role of AFP Response to Treatment on Development of Hepatocellular Carcinoma
Ulasoglu C., Senates B. E., YAPALI S., Dumanoglu B., Enc F., ÇOLAK Y., et al.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
, cilt.27, sa.2, ss.49-52, 2021 (Hakemli Dergi)
2021
202117. Sistemik Hastalıklar ve Karaciğerin Nodüler Rejeneratif Hiperplazisi
Yapali S.
Türkiye Klinikleri Gastroenterohepatoloji Dergisi , cilt.14, sa.2, ss.104-110, 2021 (TRDizin)
2021
202118. Gebeliğin Akut Yağlı Karaciğeri
Yapali S.
Türkiye Klinikleri Gastroenterohepatoloji Dergisi , cilt.14, sa.2, ss.42-48, 2021 (TRDizin)
2020
202019. Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience
Degertekin B., DEMİR M., AKARCA U. S., KANİ H. T., ÜÇBİLEK E., Yildirim E., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.31, sa.12, ss.883-893, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202020. Regular coffee intake improves liver enzyme levels and liver histology in patients with chronic alcohol consumption, non-alcoholic fatty liver and non-alcoholic steatohepatitis: Report of 259 cases
DEĞERTEKİN M. B., TÖZÜN A. N., Söylemez A. G., Gurtay E., Bozkurt U., YILMAZ Y., et al.
Hepatology Forum
, cilt.1, sa.3, ss.88-96, 2020 (Hakemli Dergi)
2020
202021. What hepatologists need to know about COVID-19?
Yapali S.
Hepatology forum , cilt.1, sa.2, ss.41-43, 2020 (Scopus)
2020
202022. Determination of the upper limits of normal serum alanine aminotransferase (ALT) level in healthy Turkish population.
Degertekin B., Tozun N., Demir F., Soylemez G., Yapali S., Bozkurt U., et al.
Hepatology forum , cilt.1, sa.2, ss.44-47, 2020 (Hakemli Dergi)
2020
202023. Determination of the upper limits of normal serum alanine aminotransferase (ALT) level in healthy Turkish population
Değertekin M. B., Tözün A. N., Demir F., Soylemez G., Yapalı S., Bozkurt U., et al.
Hepatology Forum , cilt.1, sa.2, ss.44-47, 2020 (Hakemli Dergi)
2019
201924. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the Istanbul Group
AYTAÇ E., Aslan F., ÇİÇEK B., Erdamar S., Gurses B., GÜVEN K., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.30, sa.7, ss.584-598, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201925. Nonalkolik Yağlı Karaciğer Hastalığında Noninvaziv Yöntemler
Yapalı S.
Türkiye Klinikleri , cilt.1, ss.35-40, 2019 (Hakemli Dergi)
2019
201926. Covering the Cover
Yapalı S.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.30, sa.7, ss.582-583, 2019 (SCI-Expanded)
2018
201827. The Role of New Viral Biomarkers in Chronic Hepatitis B: Ready to Use in the Clinical Practice?
Yapali S.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
, cilt.24, sa.2, ss.57-60, 2018 (Hakemli Dergi)
2018
201828. High-resolution esophageal manometry: Evaluation of differences between supine and lateral recumbent positions
Palmela C., Oors J. M., Hillenius S., YAPALI S., de Rooij W., Smout A. J. P. M., et al.
NEUROGASTROENTEROLOGY AND MOTILITY , 2018 (SCI-Expanded, Scopus)
2018
201829. COVERING THE COVER.
Yapalı S.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.29, ss.375-376, 2018 (SCI-Expanded, Scopus, TRDizin)
2018
201830. Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries
Yapalı S., Tözün A. N.
Hepatoma Resarch , cilt.4, sa.24, ss.1-10, 2018 (Hakemli Dergi)
2017
201731. Seroprevalance of hepatitis B and C infections in Turkey.
Yapali S.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.28, sa.2, ss.147-148, 2017 (SCI-Expanded, Scopus, TRDizin)
2016
201632. Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.
Patel A., Yapali S., Lok A.
Hepatology international
, cilt.10, ss.139-46, 2016 (SCI-Expanded, Scopus)
2016
201633. New treatments for chronic hepatitis C infection
Yapali S., Tozun N.
MARMARA MEDICAL JOURNAL
, cilt.29, ss.43-49, 2016 (Hakemli Dergi)
2015
201534. Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy
TURAN İ., YAPALI S., Bademkiran F., KÖSE T., DUMAN S., Sozbilen M., et al.
LIVER TRANSPLANTATION
, cilt.21, sa.8, ss.1066-1075, 2015 (SCI-Expanded, Scopus)
2015
201535. Changes in characteristics of hepatitis C patients seen in a liver centre in the United States during the last decade.
Talaat N., Yapali S., Fontana R., Conjeevaram H., Lok A.
Journal of viral hepatitis
, cilt.22, ss.481-8, 2015 (SCI-Expanded, Scopus)
2015
201536. TLR2 and TLR4 gene expression levels and associated factors during acute attack and attack-free periods in familial Mediterranean fever
Karakose M. Z., YAPALI S., Salman E., Aksu K., Karakose S., AKARCA U. S.
CLINICAL RHEUMATOLOGY
, cilt.34, sa.4, ss.785-790, 2015 (SCI-Expanded, Scopus)
2015
201537. 7 günlük standard üçlü tedaviye C ve E vitamini eklenmesiHelikobakter pilori eradikasyon oranını arttırır
GÜZELBULUT F., SEZiKLi M., ÇETiNKAYA Z. A., YAPALI S., İNCE A. T., ÖVÜNÇ O.
Akademik Gastroenteroloji , cilt.9, sa.2, ss.60-63, 2015 (Hakemli Dergi)
2015
201538. Outcomes of patients with chronic hepatitis B who do not meet criteria for antiviral treatment at presentation.
Yapali S., Talaat N., Fontana R., Oberhelman K., Lok A.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
, cilt.13, 2015 (SCI-Expanded, Scopus)
2014
201439. Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV?
Yapali S., Lok A.
Gut , cilt.63, ss.1833-4, 2014 (SCI-Expanded, Scopus)
2014
201440. Sexual activity does not predispose to reflux episodes in patients with gastroesophageal reflux disease
BOR S., Valytova E., YAPALI S., Yildirim E., VARDAR R.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
, cilt.2, sa.6, ss.482-489, 2014 (SCI-Expanded, Scopus)
2014
201441. Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring--predictors and predictive models of disease progression.
Konerman M., Yapali S., Lok A.
Alimentary pharmacology & therapeutics
, cilt.40, ss.863-79, 2014 (SCI-Expanded, Scopus)
2014
201442. A severe case of esophageal ulcer causing a tight stricture despite long-term D-penicillamine treatment
YAPALI S., TURAN İ., Ozutemiz O., Tekesin O.
WIENER KLINISCHE WOCHENSCHRIFT
, cilt.126, sa.23-24, ss.789-791, 2014 (SCI-Expanded, Scopus)
2014
201443. Potential benefit of telbivudine on renal function does not outweigh its high rate of antiviral drug resistance and other adverse effects.
Yapali S., Lok A.
Gastroenterology , cilt.146, ss.15-9, 2014 (SCI-Expanded, Scopus)
2014
201444. Management of hepatitis B: our practice and how it relates to the guidelines.
Yapali S., Talaat N., Lok A.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
, cilt.12, ss.16-26, 2014 (SCI-Expanded, Scopus)
2013
201345. Should treatment of hepatitis B patients be based solely on liver fibrosis?
Yapali S., Lok A.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
, cilt.11, ss.1500-2, 2013 (SCI-Expanded, Scopus)
2013
201346. Should this patient be treated Best practices in identifying cirrhosis and HCC in patients infected with HBV Role of prediction models
YAPALI S., LOK A. S.
Johns Hopkins Medicine eViralHepatitis Review , cilt.3, sa.3, ss.1-12, 2013 (Hakemli Dergi)
2013
201347. Giant esophageal lipoma presenting with gastroesophageal reflux symptoms.
Yapali S., Oruc N., Harman M., Aydin A.
Journal of gastrointestinal and liver diseases : JGLD , cilt.22, ss.8, 2013 (SCI-Expanded, Scopus)
2013
201348. Frontal Skull Metastasis Extending Through the Scalp: Initial Sign of Hepatocellular Carcinoma Recurrence 5 Years After Liver Transplantation
TURAN İ., YAPALI S., Ozutemiz O., KARASU A. Z.
TRANSPLANTATION
, cilt.95, sa.3, 2013 (SCI-Expanded, Scopus)
2013
201349. The role of Bernstein test with pH-impedance monitoring in different subtypes of GERD: Re-evaluation of an old technique
YAPALI S., Vardar R., Yildirim E., BOR S.
JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.47, sa.1, ss.96-97, 2013 (SCI-Expanded, Scopus)
2012
201250. Acute presentation of autoimmune hepatitis in a patient with myasthenia gravis, thymoma, Hashimoto thyroiditis and connective tissue disorder
Yapali S., ORUÇ N., Ilgun S., YILMAZ F., AKSU K., Yilmaz M., et al.
Hepatology Research
, cilt.42, sa.8, ss.835-839, 2012 (SCI-Expanded, Scopus)
2011
201151. Literatürden Seçmeler Helicobakter pilori enfeksiyonu ve özofagus hastalıkları
YAPALI S.
Skop Gastrointestinal Endoskopi Dergisi , sa.5, ss.45-47, 2011 (Hakemsiz Dergi)
2009
200952. Serum Levels of Adipokines in Patients with Chronic HCV Infection: Relationship with Steatosis and Fibrosis
TIFTIKCI A., ATUĞ Ö., YILMAZ Y., EREN F., Ozdemir F. T., Yapali S., et al.
ARCHIVES OF MEDICAL RESEARCH , cilt.40, sa.4, ss.294-298, 2009 (SCI-Expanded, Scopus)
2008
200853. Is there a role for adipocytokines on the effect of anti-TNF treatment in an experimental model of colitis?
Yapali S., Deniz M., Eren F., Imeryuz N., Celikel C., Ozkan N., et al.
GASTROENTEROLOGY , cilt.134, sa.4, 2008 (SCI-Expanded, Scopus)
2007
200754. Anti-TNF treatment in inflammatory bowel disease
Yapali S., Hamzaoglu H. O.
Annals of Gastroenterology , cilt.20, sa.1, ss.48-53, 2007 (SCI-Expanded)
Bilimsel Yayınlarda Hakemlikler
Ocak 2021
Ocak 2021HEPATOLOGY FORUM
Diğer Dergiler
Ocak 2021
Ocak 2021TURKISH JOURNAL OF GASTROENTEROLOGY
SCI-E Kapsamındaki Dergi